[Cardiovascular effects of urapidil]

Area of Science:

• Pharmacology
• Cardiovascular Research
• Adrenergic Receptor Studies

Context:

• Investigating the cardiovascular effects and mechanism of action of urapidil.
• Utilizing various in vivo and in vitro models including anesthetized and pithed rats, and isolated rat aorta.

Purpose:

• To elucidate the primary mechanism behind urapidil's hypotensive action.
• To determine whether the hypotensive effect is centrally or peripherally mediated.
• To characterize the drug's interaction with adrenergic receptors.

Summary:

• Intravenous urapidil induced significant hypotension without altering heart rate in anesthetized rats.
• Central administration of urapidil required very high doses to produce hypotension, indicating a predominantly peripheral mechanism.
• Urapidil competitively antagonizes norepinephrine-induced contractions in the rat aorta, demonstrating alpha-blocking properties.
• The drug exhibits weak vasoconstriction in pithed rats and presynaptic inhibition in the heart, contributing to the lack of heart rate changes.

Impact:

• Urapidil's hypotensive action is primarily attributed to peripheral alpha-adrenoceptor blockade.
• The findings suggest urapidil may also interact with post- or presynaptic alpha 2-adrenoceptors.
• This research provides crucial insights into urapidil's cardiovascular pharmacology for potential therapeutic applications.